Publication:
Treatment outcomes of surgery, antifungal therapy and immunotherapy in ocular and vascular human pythiosis: A retrospective study of 18 patients

dc.contributor.authorNitipong Permpalungen_US
dc.contributor.authorNavaporn Worasilchaien_US
dc.contributor.authorRongpong Plonglaen_US
dc.contributor.authorSikarin Upalaen_US
dc.contributor.authorAnawin Sanguankeoen_US
dc.contributor.authorLeilani Paitoonpongen_US
dc.contributor.authorLeonel Mendozaen_US
dc.contributor.authorAriya Chindampornen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherColumbia University, College of Physicians and Surgeonsen_US
dc.contributor.otherKing Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherMichigan State Universityen_US
dc.date.accessioned2018-11-09T03:03:06Z
dc.date.available2018-11-09T03:03:06Z
dc.date.issued2014-01-01en_US
dc.description.abstract© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. Objectives: Human pythiosis is a life-threatening disease for which no standard treatment protocols with proven efficacy exist. We present the results of our institutional pythiosis treatment protocol, composed of surgery, antifungal agents, iron chelator (only vascular cases) and immunotherapy. Methods: We retrospectively analysed patients with proven vascular and ocular pythiosis in King Chulalongkorn Memorial Hospital from April 2003 to May 2013. Fisher's exact test and Wilcoxon's rank-sum test were used. The MICs of seven antifungal agents and combination drugs were investigated in eight clinical Pythium insidiosum strains. Results: Eighteen patients were evaluated. Disease-free surgical margins were obtained in all surviving patients with vascular pythiosis (P1/40.08). Patients who underwent eye enucleation were significantly older than those who did not (P,0.05). Patients with vascular or ocular pythiosis did not differ significantly in the median time from disease onset to first surgery or in the relationship between the type of P. insidiosum antigen and treatment outcomes. In vitro susceptibility profiles of all isolates demonstrated that no single agent or combination treatment was substantially more effective than the others. The highest MIC was detected for amphotericin B, followed in order by voriconazole, fluconazole, anidulafungin, caspofungin, itraconazole and terbinafine. No synergistic effects of the combination drug treatments were found. Conclusions: Surgery with adequate surgical margins is a crucial determinant of survival in patients with vascular pythiosis. Itraconazole and terbinafine do not have synergistic effects on Thai P. insidiosum strains. The role of immunotherapy remains inconclusive for both vascular and ocular pythiosis.en_US
dc.identifier.citationJournal of Antimicrobial Chemotherapy. Vol.70, No.6 (2014), 1885-1892en_US
dc.identifier.doi10.1093/jac/dkv008en_US
dc.identifier.issn14602091en_US
dc.identifier.issn03057453en_US
dc.identifier.other2-s2.0-84930509767en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/34803
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84930509767&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleTreatment outcomes of surgery, antifungal therapy and immunotherapy in ocular and vascular human pythiosis: A retrospective study of 18 patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84930509767&origin=inwarden_US

Files

Collections